Baragetti Andrea
Associate Professor
Scientific-Disciplinary Sector
BIOS-11/A - Pharmacology
Scientific-Disciplinary Group/Competition Sector
05/BIOS-11 - FARMACOLOGIA
Research fields and competencies
Contacts
Workplace
Office phone number
Additional phone numbers
University email address
Office hours
by appointment (email)
Reception office
Dipartimento di Scienze Farmacologiche e Biomolecolari "Rodolfo Paoletti", via Balzaretti 9, Milano
Teaching - Programme courses
Bachelors and masters
A.Y. 2025/2026
A.Y. 2024/2025
A.Y. 2023/2024
A.Y. 2022/2023
A.Y. 2021/2022
Postgraduate programmes
A.Y. 2024/2025
Doctoral programme (PhD)
A.Y. 2023/2024
Doctoral programme (PhD)
A.Y. 2022/2023
Research
Publications
-
Targeting PCSK9 beyond the liver: evidence from experimental and clinical studies / L. Da Dalt, A. Baragetti, G. Norata. - In: EXPERT OPINION ON THERAPEUTIC TARGETS. - ISSN 1472-8222. - 29:3(2025 Mar), pp. 136-157. [10.1080/14728222.2025.2482545]
-
Exploring neutrophils as therapeutic targets in cardiometabolic diseases / M. Albiero, A. Baragetti. - In: TRENDS IN PHARMACOLOGICAL SCIENCES. - ISSN 0165-6147. - (2025), pp. 1-15. [10.1016/j.tips.2024.12.003]
-
ASGR1 deficiency improves atherosclerosis but alters liver metabolism in ApoE-/- mice / M. Svecla, A. Moregola, L.D. Dalt, J. Nour, A. Baragetti, P. Uboldi, A. Idini, M. Wuhrer, G. Beretta, D. Falck, F. Bonacina, G.D. Norata. - In: CARDIOVASCULAR DIABETOLOGY. - ISSN 1475-2840. - 23:1(2024 Nov 30), pp. 428.1-428.14. [10.1186/s12933-024-02507-5]
-
New insights into the therapeutic options to lower lipoprotein(a) / A. Baragetti, L. Da Dalt, G. Norata. - In: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - ISSN 1365-2362. - 54:9(2024 Sep), pp. e14254.1-e14254.15. [10.1111/eci.14254]
-
Plasma proteins associate with carotid plaques and predict incident atherosclerotic cardiovascular events / A. Baragetti, L. Grigore, E. Olmastroni, E. Mattavelli, A. Catapano. - In: VASCULAR PHARMACOLOGY. - ISSN 1537-1891. - 156:(2024 Sep), pp. 107394.1-107394.10. [10.1016/j.vph.2024.107394]